These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 25218825)
1. Fighting Ebola with ZMapp: spotlight on plant-made antibody. Zhang Y; Li D; Jin X; Huang Z Sci China Life Sci; 2014 Oct; 57(10):987-8. PubMed ID: 25218825 [No Abstract] [Full Text] [Related]
2. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Olinger GG; Pettitt J; Kim D; Working C; Bohorov O; Bratcher B; Hiatt E; Hume SD; Johnson AK; Morton J; Pauly M; Whaley KJ; Lear CM; Biggins JE; Scully C; Hensley L; Zeitlin L Proc Natl Acad Sci U S A; 2012 Oct; 109(44):18030-5. PubMed ID: 23071322 [TBL] [Abstract][Full Text] [Related]
3. Two-mAb cocktail protects macaques against the Makona variant of Ebola virus. Qiu X; Audet J; Lv M; He S; Wong G; Wei H; Luo L; Fernando L; Kroeker A; Fausther Bovendo H; Bello A; Li F; Ye P; Jacobs M; Ippolito G; Saphire EO; Bi S; Shen B; Gao GF; Zeitlin L; Feng J; Zhang B; Kobinger GP Sci Transl Med; 2016 Mar; 8(329):329ra33. PubMed ID: 26962157 [TBL] [Abstract][Full Text] [Related]
4. WHO gives go ahead for experimental treatments to be used in Ebola outbreak. Sayburn A BMJ; 2014 Aug; 349():g5161. PubMed ID: 25122051 [No Abstract] [Full Text] [Related]
7. Nubia's mother: being pregnant in the time of experimental vaccines and therapeutics for Ebola. Caluwaerts S Reprod Health; 2017 Dec; 14(Suppl 3):157. PubMed ID: 29297408 [TBL] [Abstract][Full Text] [Related]
12. US signs contract with ZMapp maker to accelerate development of the Ebola drug. McCarthy M BMJ; 2014 Sep; 349():g5488. PubMed ID: 25189475 [No Abstract] [Full Text] [Related]
13. Infectious diseases. Debate erupts on 'repurposed' drugs for Ebola. Enserink M Science; 2014 Aug; 345(6198):718-9. PubMed ID: 25124404 [No Abstract] [Full Text] [Related]
14. [What is new in . . . Infectious diseases: Advancements and setbacks]. Tattevin P Rev Prat; 2015 Dec; 65(10):1295-8. PubMed ID: 26979027 [No Abstract] [Full Text] [Related]
15. Statistical considerations for a trial of Ebola virus disease therapeutics. Proschan MA; Dodd LE; Price D Clin Trials; 2016 Feb; 13(1):39-48. PubMed ID: 26768567 [TBL] [Abstract][Full Text] [Related]
16. The early clinical development of Ebola virus treatments. Bradfute SB Expert Opin Investig Drugs; 2017 Jan; 26(1):1-4. PubMed ID: 27838928 [No Abstract] [Full Text] [Related]
17. Ebola drug trial is terminated after fall in number of new cases. Gulland A BMJ; 2015 Feb; 350():h664. PubMed ID: 25656547 [No Abstract] [Full Text] [Related]
18. Pharmacotherapy of Ebola hemorrhagic fever: a brief review of current status and future perspectives. Olszanecki R; Gawlik G Folia Med Cracov; 2014; 54(3):67-77. PubMed ID: 25694097 [TBL] [Abstract][Full Text] [Related]
19. FDA allows second experimental drug to be tested in Ebola patients. McCarthy M BMJ; 2014 Aug; 349():g5103. PubMed ID: 25113141 [No Abstract] [Full Text] [Related]
20. Ebola: public-private partnerships. Reperant LA; van de Burgwal LH; Claassen E; Osterhaus AD Science; 2014 Oct; 346(6208):433-4. PubMed ID: 25342793 [No Abstract] [Full Text] [Related] [Next] [New Search]